2023
DOI: 10.1002/adma.202307980
|View full text |Cite
|
Sign up to set email alerts
|

Ultrasound‐Driven Non‐Metallic Fenton‐Active Center Construction for Extensive Chemodynamic Therapy

Jiyue Wu,
Yun Meng,
Fan Wu
et al.

Abstract: Chemodynamic therapy (CDT) is an emerging tumor microenvironment‐responsive cancer therapeutic strategy based on Fenton/Fenton‐like reactions. However, the effectiveness of CDT is subject to the slow kinetic rate and non‐homogeneous distribution of H2O2. In this study, a conceptual non‐metallic “Fenton‐active” center construction strategy is proposed to enhance CDT efficiency using Bi0.44Ba0.06Na0.5TiO3 (BNBT‐6) nanocrystals. The separated charge carriers under a piezoelectric‐induced electric field synchroniz… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 15 publications
(3 citation statements)
references
References 43 publications
0
3
0
Order By: Relevance
“…Comparatively, stronger fluorescence signals are observed in HeLa cells treated with H-MoN 5 @PtN 4 /C (Figure d-ii), indicating that H-MoN 5 @PtN 4 /C can catalyze cascade enzymatic reactions to generate high levels of O 2 •– . In the meantime, in situ • OH produced by the POD-like activity of H-MoN 5 @PtN 4 /C was recorded in cancer cells using aminophenol fluorescein (APF) as the fluorescent probe . As shown in Figure d-iii, the green fluorescence is strongest in cells after incubation with H-MoN 5 @PtN 4 /C, which is ascribed to synergistically enhanced POD-like performance generated by an axial coordination configuration.…”
Section: Resultsmentioning
confidence: 97%
See 1 more Smart Citation
“…Comparatively, stronger fluorescence signals are observed in HeLa cells treated with H-MoN 5 @PtN 4 /C (Figure d-ii), indicating that H-MoN 5 @PtN 4 /C can catalyze cascade enzymatic reactions to generate high levels of O 2 •– . In the meantime, in situ • OH produced by the POD-like activity of H-MoN 5 @PtN 4 /C was recorded in cancer cells using aminophenol fluorescein (APF) as the fluorescent probe . As shown in Figure d-iii, the green fluorescence is strongest in cells after incubation with H-MoN 5 @PtN 4 /C, which is ascribed to synergistically enhanced POD-like performance generated by an axial coordination configuration.…”
Section: Resultsmentioning
confidence: 97%
“…In the meantime, in situ • OH produced by the POD-like activity of H-MoN 5 @PtN 4 /C was recorded in cancer cells using aminophenol fluorescein (APF) as the fluorescent probe. 45 As shown in Figure 5d-iii, the green fluorescence is strongest in cells after incubation with H-MoN 5 @PtN 4 /C, which is ascribed to synergistically enhanced POD-like performance generated by an axial coordination configuration. Consequently, the proposed H-MoN 5 @PtN 4 /C can effectively accumulate intracellular ROS (O 2…”
Section: ■ Introductionmentioning
confidence: 80%
“…Researchers such as Bu and others have developed various chemodynamic therapy agents and demonstrated their significant effectiveness in inhibiting tumor progression. 20,21 However, some of these agents have a tendency to accumulate in normal tissues after intravenous administration, which can result in side effects during treatment. Therefore, engineering the design of microspheres to carry PTT and CDT agents allows for localized delivery, effectively addressing the challenges of TACE microspheres’ drug resistance and potential harm to normal tissues.…”
Section: Introductionmentioning
confidence: 99%